1. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma
    Zhao-Shan Niu et al, 2020, World Journal of Gastroenterology CrossRef
  2. Research on preparation and antitumor activity of redox-responsive polymer micelles co-loaded with sorafenib and curcumin
    Fangshu Liu et al, 2023, Journal of Biomaterials Science, Polymer Edition CrossRef
  3. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
    Jiao Feng et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef

  4. LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway


    Qian Shen et al, 2020, Cancer Management and Research CrossRef
  5. Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
    Grégory Fouquet et al, 2022, Cancers CrossRef
  6. Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
    Li-Zhu Liao et al, 2020, International Journal of Molecular Sciences CrossRef
  7. Apoptotic Effects of Xanthium strumarium via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
    Juyoung Kim et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  8. Coumarin-acetohydrazide derivatives as novel antiproliferative agents via VEGFR-2/AKT axis inhibition and apoptosis triggering
    Lina M. A. Abdel Ghany et al, 2022, New Journal of Chemistry CrossRef
  9. GHR knockdown enhances the sensitivity of HCC cells to sorafenib
    Shuang Gao et al, 2020, Aging CrossRef
  10. In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers
    Rana M. Abdelnaby et al, 2022, Pharmaceuticals CrossRef
  11. CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth
    J. H. Azambuja et al, 2019, Molecular Neurobiology CrossRef
  12. A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
    Mai-Huong T. Ngo et al, 2021, Cancers CrossRef
  13. AZD4547 and the Alleviation of Hepatoma Cell Sorafenib Resistance via the Promotion of Autophagy
    Yun Feng et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  14. Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma
    Yi-Jen Liao et al, 2020, Molecules CrossRef
  15. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
    Monica Mossenta et al, 2020, Cancers CrossRef
  16. Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway
    Chengdong Qin et al, 2023, Frontiers in Pharmacology CrossRef
  17. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
    Zhi Zeng et al, 2021, Frontiers in Oncology CrossRef